Cancer research
Engineered iPSC-Derived Natural Killer Cells: Advances in Cancer Immunotherapy
Researchers from the University of Queensland have made significant breakthroughs in generating induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells for cancer immunotherapy. According to a recent review published in Clinical & Translational Immunology, these cells hold promise as a scalable, consistent, and inexhaustible source of genetically modifiable